<DOC>
	<DOCNO>NCT01391598</DOCNO>
	<brief_summary>The study 's primary objective evaluate effect intravenous lidocaine pain plasma interleukin-1 ( IL-1 ) , interleukin-6 ( IL-6 ) substance P patient fibromyalgia . As secondary objective : evaluate clinical manifestation , plasma concentration lidocaine .</brief_summary>
	<brief_title>Lidocaine Pain Relief IL Substance P Fibromyalgia</brief_title>
	<detailed_description>Fibromyalgia painful syndrome characterize chronic diffuse pain involvement multiple muscle soft tissue 1 . The pain common , prevalence around 2 % adult population . In fibromyalgia , increase somatic visceral nociception , dysfunction central nervous.system According American College Rheumathology diagnostic criterion fibromyalgia widespread pain presence 11 18 typical tender point 3 . Minor criterion inclusion patient diagnosis fibromyalgia , pain change physical activity , sleep disturbance , fatigue , anxiety , depression , paresthesia , cramp , sensation swell 4 . Several co-morbidities may associate pain migraine , myofascial pain syndrome , irritable bowel syndrome . The symmetry condition show fibromyalgia associate central sensitization 5 . The pathophysiological mechanism fibromyalgia relate change neurotransmitter 6,7,8 . Cytokines may involve modulation symptom hyperalgesia , fatigue depression , maintenance sympathetic pain 9 . ] The substance P ( SP ) level increase cerebrospinal fluid patient fibromyalgia compare control group 10 . Antidepressants widely use drug treatment . The drug commonly use amitriptyline . Other drug ( muscle relaxant , anticonvulsant , NSAIDs , tramadol ) also employ . Physical activity essential control symptom . Physical measure , psychotherapy , occupational therapy treatment , effectiveness variable 14.15 . Sometimes combination drug technique need obtain satisfactory result . The infusion local anesthetic give intravenously fibromyalgia oral medication produce proper effect . It promote sympathetic blockade , vasodilation , anesthesia nerve ending vascular endothelium , stabilization membrane break vicious circle keep pain 16 . Local anesthetic membrane-stabilizing prevent generation ectopic impulse low concentration need block normal driving . The dose use different author range 1 5 mg / kg , administer 30-60 minute 17-24 . Side effect lidocaine : sedation , vertigo , dizziness , blur vision , nausea vomit 25 . The effectiveness intravenous lidocaine neuropathic pain well establish 26 . Despite evidence analgesic effect , controversy condition without nerve injury . It may selectivity effect non-neuropathic neuropathic pain relative depend plasma concentration reached25 . For use systemic lidocaine fibromyalgia , well-controlled study , ass change cytokine substance P , stimulate research .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<criteria>Patients fibromyalgia include study classification criterion propose American College Rheumatology ( generalize hypersensitivity pain stiffness 11 18 musculotendinous insertion site least three month four quadrant body , absence traumatic injury , rheumatic disease , neuromuscular infectious arthropathy ) . Will exclude study patient : cognitive language comprehension ; abnormal laboratory test , trauma , psychiatric illness , rheumatic neuromuscular another pain syndrome , infectious arthropathy , hypersensitivity drug pregnant . Also exclude patient arrhythmia , myocardial infarction , concomitant use cisapride monoamine oxidase inhibitor , bundle branch block atrioventricular heart failure , acute , angle glaucoma , myasthenia gravis , severe liver disease hyperthyroidism ; use centrally act analgesic medication ( antidepressant , anticonvulsant , opioids , neuroleptic ) least 4 week baseline . Patients experience severe side effect relate infusion lidocaine ( severe hypotension seizure ) exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>fibromyalgia</keyword>
	<keyword>intravenous lidocaine</keyword>
	<keyword>substance P</keyword>
	<keyword>interleukin</keyword>
</DOC>